Approvals/TGA/Mesalazine 1.2 TAKEDA (mesalazine) 1.2 g prolonged release tablet blister pack

Approved

STANDARD

Mesalazine 1.2 TAKEDA (mesalazine) 1.2 g prolonged release tablet blister pack

Takeda Pharmaceuticals Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 084fbd8d863eae5b
Product Name: Mesalazine 1.2 TAKEDA (mesalazine) 1.2 g prolonged release tablet blister pack
Artg Id: 316122
Artg Name: Mesalazine 1.2 TAKEDA (mesalazine) 1.2 g prolonged release tablet blister pack
Sponsor: Takeda Pharmaceuticals Australia Pty Ltd
Company Detail Path: /organization/takeda-pharmaceuticals-australia-pty-ltd
Artg Date: 2021-01-07
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/61cb30549206a129a61db35699230d55.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/dccdfa416a05d6d4b564036937da2b45.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

084fbd8d863eae5b

Type

Standard